Growth Metrics

Cytosorbents (CTSO) Net Margin (2011 - 2026)

Cytosorbents posted quarterly Net Margin of 57.86% for Q1 2026, down 4092.0% year-on-year from 1.45% in Q1 2025, and up 2.8% on a QoQ basis from 59.53% in Q4 2025.

Cytosorbents (CTSO) has 16 years of Net Margin data on file, last reported at 57.86% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 4092.0% year-over-year to 57.86%; the trailing twelve-month figure through Mar 2026 stood at 31.85% (up 1374.0% YoY), and the FY2025 full-year result was 22.12%, up 3609.0% from the prior year.
  • Net Margin for Q1 2026 stood at 57.86%, up from 59.53% in the prior quarter.
  • Across five years, Net Margin topped out at 20.25% in Q2 2025 and bottomed at 150.42% in Q3 2022.
  • The 5-year median for Net Margin is 65.31% (2023), against an average of 63.88%.
  • Peak annual rise in Net Margin reached 7816 bps in 2022, while the deepest fall reached 8916 bps in 2022.
  • A 5-year view of Net Margin shows it stood at 8.16% in 2022, then tumbled by 725 bps to 67.31% in 2023, then slipped by 23 bps to 82.69% in 2024, then advanced by 28 bps to 59.53% in 2025, then advanced by 3 bps to 57.86% in 2026.
  • The last three Net Margin figures came in at 57.86% (Q1 2026), 59.53% (Q4 2025), and 33.42% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.65%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.38%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 12.75%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.01%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -57.86%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -57.86%
Dec 31, 2025 -59.53%
Sep 30, 2025 -33.42%
Jun 30, 2025 20.25%
Mar 31, 2025 -16.95%
Dec 31, 2024 -82.69%
Sep 30, 2024 -32.14%
Jun 30, 2024 -48.56%
Mar 31, 2024 -70.73%
Dec 31, 2023 -67.31%
Sep 30, 2023 -104.34%
Jun 30, 2023 -65.31%
Mar 31, 2023 -77.53%
Dec 31, 2022 -8.16%
Sep 30, 2022 -150.42%
Jun 30, 2022 -128.06%
Mar 31, 2022 -103.16%
Dec 31, 2021 -86.32%
Sep 30, 2021 -65.64%
Jun 30, 2021 -38.90%
Mar 31, 2021 -39.32%
Dec 31, 2020 -5.67%
Sep 30, 2020 -7.96%
Jun 30, 2020 -29.27%
Mar 31, 2020 -39.65%
Dec 31, 2019 -53.15%
Sep 30, 2019 -112.96%
Jun 30, 2019 -56.92%
Mar 31, 2019 -94.07%
Dec 31, 2018 -88.86%
Sep 30, 2018 -52.32%
Jun 30, 2018 -101.14%
Mar 31, 2018 -60.55%
Dec 31, 2017 -67.73%
Sep 30, 2017 -53.72%
Jun 30, 2017 -58.05%
Mar 31, 2017 -48.98%
Dec 31, 2016 -159.10%
Sep 30, 2016 -90.73%
Jun 30, 2016 -126.66%
Mar 31, 2016 -102.45%
Dec 31, 2015 -143.64%
Sep 30, 2015 -154.52%
Jun 30, 2015 -224.34%
Mar 31, 2015 -374.65%
Dec 31, 2014 -1,200.87%
Sep 30, 2014 -239.12%
Jun 30, 2014 -315.02%
Mar 31, 2014 -196.73%
Dec 31, 2013 -69.79%
Sep 30, 2013 -220.04%
Jun 30, 2013 -1,587.48%
Mar 31, 2013 -1,258.03%
Dec 31, 2012 -1,339.46%
Sep 30, 2012 -9,369.87%
Jun 30, 2012 -3,249.03%
Mar 31, 2012 -4,162.21%
Dec 31, 2011 -5,348.33%